These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24433215)

  • 1. Risk of herpes zoster in psoriatic patients undergoing biologic treatment.
    Umezawa Y; Fukuchi O; Ito T; Saeki H; Nakagawa H
    J Dermatol; 2014 Feb; 41(2):168-70. PubMed ID: 24433215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Herpes zoster in patients with psoriasis treated with biologic drugs.
    Dreiher J; Kresch FS; Comaneshter D; Cohen AD
    J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1127-32. PubMed ID: 21923837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Therapy for Psoriasis and the Risk of Herpes Zoster: A 500,000 Person-year Study.
    Shalom G; Zisman D; Bitterman H; Harman-Boehm I; Greenberg-Dotan S; Dreiher J; Feldhamer I; Moser H; Hammerman A; Cohen Y; Cohen AD
    JAMA Dermatol; 2015 May; 151(5):533-8. PubMed ID: 25797026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ustekinumab and herpes zoster.
    Failla V; Nikkels AF
    Dermatology; 2011; 222(2):119-22. PubMed ID: 21266799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes zoster in patients treated with biologicals.
    Failla V; Jacques J; Castronovo C; Nikkels AF
    Dermatology; 2012; 224(3):251-6. PubMed ID: 22677775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting.
    Navarro R; Vilarrasa E; Herranz P; Puig L; Bordas X; Carrascosa JM; Taberner R; Ferrán M; García-Bustinduy M; Romero-Maté A; Pedragosa R; García-Diez A; Daudén E
    Br J Dermatol; 2013 Mar; 168(3):609-16. PubMed ID: 22985451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions.
    Adelzadeh L; Jourabchi N; Wu JJ
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):846-52. PubMed ID: 25081573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological treatment for psoriasis and the risk of herpes zoster: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
    Shalom G; Naldi L; Lebwohl M; Nikkels A; de Jong EMGJ; Fakharzadeh S; Goyal KG; Srivastava B; Langholff W; Galindo C; Cohen AD
    J Dermatolog Treat; 2019 Sep; 30(6):534-539. PubMed ID: 29619848
    [No Abstract]   [Full Text] [Related]  

  • 9. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug survival rates in patients with psoriasis after treatment with biologics.
    Umezawa Y; Nobeyama Y; Hayashi M; Fukuchi O; Ito T; Saeki H; Nakagawa H
    J Dermatol; 2013 Dec; 40(12):1008-13. PubMed ID: 24304288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients.
    Prignano F; Ricceri F; Pescitelli L; Zanieri F; Lotti T
    Br J Dermatol; 2011 Mar; 164(3):645-7. PubMed ID: 21375517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onychomycosis in patients of nail psoriasis on biologic therapy: a randomized, prospective open label study comparing Etanercept, Infliximab and Adalimumab.
    Al-Mutairi N; Nour T; Al-Rqobah D
    Expert Opin Biol Ther; 2013 May; 13(5):625-9. PubMed ID: 23527597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris.
    Gniadecki R; Kragballe K; Dam TN; Skov L
    Br J Dermatol; 2011 May; 164(5):1091-6. PubMed ID: 21219290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ustekinumab treatment in patients with psoriasis undergoing hemodialysis.
    Umezawa Y; Hayashi M; Kikuchi S; Fukuchi O; Yanaba K; Ito T; Asahina A; Saeki H; Nakagawa H
    J Dermatol; 2015 Jul; 42(7):731-4. PubMed ID: 25959602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: a review.
    Kamili QU; Miner A; Hapa A; Menter A
    J Drugs Dermatol; 2011 May; 10(5):539-44. PubMed ID: 21533302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre.
    Wee JS; Petrof G; Jackson K; Barker JN; Smith CH
    Br J Dermatol; 2012 Aug; 167(2):411-6. PubMed ID: 22404545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes zoster in Crohn's disease during treatment with infliximab.
    Wang X; Zhao J; Zhu S; Xia B
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):237-9. PubMed ID: 24216569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib and the increased incidence of herpes zoster in patients with multiple myeloma.
    Kim SJ; Kim K; Kim BS; Lee HJ; Kim H; Lee NR; Nam SH; Kwon JH; Kim HJ; Sohn SK; Won JH; Lee JH; Suh C; Yoon SS; Kim HJ; Kim I; Do YR; Lee WS; Joo YD; Shin HJ;
    Clin Lymphoma Myeloma; 2008 Aug; 8(4):237-40. PubMed ID: 18765311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal influenza A(H1N1) respiratory tract infection in a patient having psoriasis treated with infliximab.
    Kling MC; Larian AA; Scordi-Bello I; Emer J; Lebwohl MG
    Arch Dermatol; 2010 Jun; 146(6):651-4. PubMed ID: 20566928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination use of ustekinumab with other systemic therapies: a retrospective study in a tertiary referral center.
    Heinecke GM; Luber AJ; Levitt JO; Lebwohl MG
    J Drugs Dermatol; 2013 Oct; 12(10):1098-102. PubMed ID: 24085044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.